Source comparison
Tesamorelin Cost Per Month Budget: Branded vs Compounded Comparison
Branded Egrifta (retail pharmacy) $4,000–$5,500 60mg (2mg daily × 30 days) $66.67–$91.67/mg Full FDA approval as finished drug product Covered only for HIV-associated lipodystrophy Yes. Specialist prescriber typically required Highest cost, narrow insurance co
This comparison does not assign a generated winner or score.
- Branded Egrifta (retail pharmacy)
- $4,000–$5,500
- 60mg (2mg daily × 30 days)
- $66.67–$91.67/mg
- Full FDA approval as finished drug product
- Covered only for HIV-associated lipodystrophy
- Yes. Specialist prescriber typically required
- Highest cost, narrow insurance coverage, identical peptide to compounded versions
- Compounded (503B facility)
- $200–$450
- $3.33–$7.50/mg
- FDA-registered facility, USP sterile compounding standards
- Rarely covered. Considered off-label
- Yes. Telehealth or primary care prescriber sufficient
- 85–95% cost reduction, same amino acid sequence, legal when prescribed
- Research-grade (licensed peptide supplier)
- $150–$300
- 30–90mg depending on volume tier
- $1.67–$10.00/mg
- Synthesized under GMP, sold for research use only
- Not applicable. Non-clinical product
- Not applicable. Sold for research purposes
- Lowest cost per milligram, requires research context, highest procurement flexibility
- The bottom line: branded tesamorelin costs 12–18× more than compounded versions for the same peptide. If insurance won't cover Egrifta. And it won't unless you have documented HIV lipodystrophy. Compounded tesamorelin from a 503B facility or research-grade peptide from a licensed supplier like Real Peptides delivers identical therapeutic mechanism at a fraction of the cost.